Skip to content

Arthrex® AR-8963AL-12Recalls & reported problems

Arthrex, Inc. · ANTEROLAT DIST TIB PLT, SS, LEFT, 12H · Class 2 · Implant

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00888867223097), received between Jan 27, 2020 and Jan 27, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Break1

Patient problems

  • No Code Available1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryJan 27, 2020Break

    IT WAS REPORTED THAT THE IMPLANTED PLATE BROKE FOUR WEEKS AFTER THE INITIAL SURGERY. A REVISION SURGERY WAS PERFORMED ON (B)(6) 2019. THE SURGEON HAS USED A NAIL TO SUCCESSFULLY PERFORM THE SURGERY. ADDITIONAL INFORMATION 14-JAN-2020: FURTHER INFORMATION WERE RECEIVED THAT THE INITIAL PROCEDURE WAS A REVISION TIBIA & FIBULA FRACTURE SURGERY.

    Patient problems: No Code Available

    MAUDE report 9631820 ↗

Other Plate, fixation, bone devices

All Plate, fixation, bone devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page